Food proteins are a potential resource for mining cathepsin L inhibitory drugs to combat SARS-CoV-2

Eur J Pharmacol. 2020 Oct 15:885:173499. doi: 10.1016/j.ejphar.2020.173499. Epub 2020 Aug 22.

Abstract

The entry of SARS-CoV-2 into host cells proceeds by a proteolysis process, which involves the lysosomal peptidase cathepsin L. Inhibition of cathepsin L is therefore considered an effective method to decrease the virus internalization. Analysis from the perspective of structure-functionality elucidates that cathepsin L inhibitory proteins/peptides found in food share specific features: multiple disulfide crosslinks (buried in protein core), lack or low contents of (small) α-helices, and high surface hydrophobicity. Lactoferrin can inhibit cathepsin L, but not cathepsins B and H. This selective inhibition might be useful in fine targeting of cathepsin L. Molecular docking indicated that only the carboxyl-terminal lobe of lactoferrin interacts with cathepsin L and that the active site cleft of cathepsin L is heavily superposed by lactoferrin. A controlled proteolysis process might yield lactoferrin-derived peptides that strongly inhibit cathepsin L.

Keywords: COVID-19; Food; Infection; Lactoferrin; Protein; Virus.

MeSH terms

  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Betacoronavirus / drug effects*
  • Betacoronavirus / physiology*
  • Cathepsin L / antagonists & inhibitors*
  • Food*
  • Lactoferrin / chemistry
  • Lactoferrin / pharmacology*
  • Protease Inhibitors / chemistry
  • Protease Inhibitors / pharmacology*
  • SARS-CoV-2
  • Virus Internalization / drug effects

Substances

  • Antiviral Agents
  • Protease Inhibitors
  • Lactoferrin
  • Cathepsin L